BB Biotech AG | Mutual Funds
Mutual Funds that own BB Biotech AG
Vanguard Total International Stock Index Fund
792,248
1.43%
7,761
0.02%
07/31/2018
Vanguard Developed Markets Index Fund
310,665
0.56%
0
0.02%
07/31/2018
Bellevue Funds (Lux) - BB Global Macro
252,600
0.46%
32,100
4.07%
07/31/2018
UBAM - Swiss Equity
248,397
0.45%
-29,372
0.93%
12/31/2017
214,000
0.39%
49,000
5.93%
06/29/2018
Alecta Pension
200,983
0.36%
200,983
0.01%
12/31/2017
184,625
0.33%
184,625
3.91%
06/30/2017
European Investment Trust Plc (The)
174,030
0.31%
-38,373
2.18%
06/30/2018
Suedwestbank Vermoegensmandat Aktien
150,000
0.27%
0
3.15%
07/31/2018
Investors European Mid Cap Equity Fund
148,662
0.27%
40,246
0.91%
03/31/2018
| Address |
Schwertstrasse 6
Schaffhausen Zurich 8200
Switzerland
|
|
Employees
|
- |
| Website |
http://www.bbbiotech.com |
| Updated |
09/14/2018 |
| BB Biotech AG is a closed-end investment fund, which engages in investing in biotechnology companies. It focuses on companies whose products address areas of significant unmet medical needs and generates above-average sales and profit growth. The company was founded on November 9, 1993 and is headquartered in Schaffhausen, Switzerland. |
